1)Gefitinib(Iressa)吉非替尼(易瑞沙)
2)gefitinib吉非替尼
1.An improved synthetic process for gefitinib;吉非替尼的合成工艺改进
2.Antiproliferative effects on non-small cell lung cancer cells by combining Tamoxifen and Gefitinib;联合应用三苯氧胺和吉非替尼对NSCLC细胞的抗增殖效应
英文短句/例句
1.Gifitinib in the Treatment for 22 Cases with Advanced Non-small Cell Lung Cancer吉非替尼治疗22例晚期非小细胞肺癌
2.Clinical Observation of Gefitinib and Eelotinib in Treatment with Non-small Cell Lung Cancer吉非替尼与厄罗替尼治疗晚期非小细胞肺癌的临床分析
3.Safety and Efficacy of Gefitinib for Treatment of Advanced Non-small Cell Lung Cancer;吉非替尼(Gefitinib)治疗晚期非小细胞肺癌的临床研究
4.The Clinical Study of Gefitinib in the Treatment of Advanced Non-small Cell Lung Cancer;吉非替尼治疗晚期非小细胞肺癌的临床观察
5.Gefinib in Treatment of Advanced NonSmall Cell Lung Cancer :Clinical Observation of 32 Cases吉非替尼治疗晚期非小细胞肺癌32例疗效观察
6.Clinical efficacy analysis of Gefitinib in the treatment of non-small cell lung cancer吉非替尼治疗晚期非小细胞肺癌临床疗效分析
7.Gefitinib in the treatment of advanced non-small cell Lung cancer failed to prioy chemotherapy吉非替尼二线治疗晚期非小细胞肺癌临床研究
8.Clinical experience of gefitinib in treatment of advanced non-small cell lung cancer吉非替尼治疗晚期非小细胞肺癌临床观察
9.Systemic Evaluation of Gefitinib in the Treatment of Non-small-cell Lung Cancer吉非替尼治疗晚期非小细胞肺癌的系统评价
10.Gefitinib in the treatment of patients with advanced non-small cell lung cancer吉非替尼治疗晚期非小细胞肺癌临床研究
11.Treatment Options for Non-Small Cell Lung Cancer in View of Inefficacy of Gefitinib非小细胞肺癌吉非替尼失败后的治疗选择
12.Efficacy of gefitinib in outpatients with advanced non-small cell lung cancer吉非替尼门诊治疗晚期非小细胞肺癌疗效观察
13.Clinical observation of gefitinib as the treatment for patients with advanced stage non-small cell lung cancer吉非替尼治疗晚期非小细胞肺癌7例临床观察
14.Gefitinib Induced Apoptosis in Lung Cancer Cell Lines and the Study of Its Interrelated Mechanism;吉非替尼诱导肺癌细胞凋亡及其机制研究
15.Death from pulmonary interstitial fibrosis and liver damage after taking gefitinib吉非替尼诱发肺间质纤维化及肝损害死亡
16.Therapeutic divergence phenomenon of gefitinib in the treatment of nonsmall cell lung cancer吉非替尼在肺癌治疗中的疗效分离现象
17.Gefitinib in the Treatment for Failed Chemotherapy and Radiotherapy in 54 Cases with Advanced Lung Adenocarcinoma吉非替尼治疗放化疗失败晚期肺腺癌患者54例
18.Effects of gefitinib on EGFR mutation in the prognosis of advanced lung cancer吉非替尼对EGFR基因突变型晚期肺癌患者的影响
相关短句/例句
gefitinib吉非替尼
1.An improved synthetic process for gefitinib;吉非替尼的合成工艺改进
2.Antiproliferative effects on non-small cell lung cancer cells by combining Tamoxifen and Gefitinib;联合应用三苯氧胺和吉非替尼对NSCLC细胞的抗增殖效应
3)gefitinib吉非替尼(Gefitinib)
1.Safety and Efficacy of Gefitinib for Treatment of Advanced Non-small Cell Lung Cancer;吉非替尼(Gefitinib)治疗晚期非小细胞肺癌的临床研究
4)gefitinib(ZD1839)吉非替尼(ZD1839)
5)Iressa易瑞沙
1.Treatment with Iressa in advanced non-small-cell lung cancer patients who failed in previous chemotherapy——10 cases report;易瑞沙治疗化疗失败的晚期非小细胞肺癌疗效分析
2.Iressa in the Treatment of Advanced Non-Small Cell Lung Cancer Failed to Prioy Chemotherapy;易瑞沙治疗化疗失败的晚期非小细胞肺癌
3.Iressa in the treatment of 24 cases of advanced non-small cell lung cancer patients who had failed to previous chemotherapy;易瑞沙在24例化疗后进展的晚期非小细胞肺癌中的作用
6)Gefitinib/radiosensitizer吉非替尼/放射增敏剂
延伸阅读
尼扎替定 ,爱希 ,尼扎替丁药物名称:尼扎替丁英文名:Nizatidine别名:尼扎替定 ,爱希 ,尼扎替丁 外文名: nizatidine ,axid 适应症: 参阅"用量" 用量用法: 活动性十二指肠溃疡及良性胃溃疡300mg qd。维持治疗150 mg qd。维持治疗 150 mg qd。胃食管反流性疾病 成人 150 mg bid。参阅说明书。 不良反应: 贫血,荨麻疹,出汗。 注意事项: 使用本药后症状改善并不能排除癌症的可能性。中至重度肾功能不全者、妊娠及哺乳妇女慎用。 规格: 胶囊 150 mg x 6粒。 类别:制酸药与抗消化性溃疡药
